About Tridem Bioscience
Tridem Bioscience is focusing on the discovery and development of innovative active immunotherapies based on our proprietary WISIT (WIn the Skin Immune system Trick) technology. We aim to realize this novel vaccine concept using Parkinson’s disease (PD) as our first indication. PD is the major representative of synucleopathies, a group of neurodegenerative diseases with high-unmet medical need.
- Employees
- 1 to 10
Leadership
The top of Tridem Bioscience's org chart, with how many people report into each leader.
MM
Markus Mandler
CEO and Founder
Jobs at Tridem Bioscience
No open positions right now. Explore more companies on TheJobsMap.